BioScrip Announces Stanley Rosenbaum As CFO; CFO to Help Develop Profitable Growth Strategy.

ELMSFORD, N.Y. -- BioScrip, Inc. (NASDAQ: BIOS) today announced that it has named Stanley Rosenbaum as Executive Vice President, Chief Financial Officer and Treasurer. Mr. Rosenbaum will assume these positions effective immediately.

"We are very pleased to appoint Stanley Rosenbaum to the position of Chief Financial Officer," commented Richard H. Friedman, Chairman and Chief Executive Officer of BioScrip, Inc. "Stan's broad experience, expertise and sound financial and operations oriented decision-making will help BioScrip develop a profitable growth strategy and achieve cost reductions."

Mr. Rosenbaum previously served as a Group Vice President of Operations and Vice President CFO - Consumer Publishing for Simon & Schuster, Inc., an international publishing concern. Prior to that, he served as the Vice President / Controller of U.S. Operations for Rhone-Poulenc/ Revlon Healthcare Group.

"I'm excited to be appointed BioScrip's EVP, CFO and Treasurer," said Rosenbaum. "I believe that BioScrip has significant growth opportunities ahead of it. I am confident that we will be able to meet the challenges facing our finance and IT departments as we meet the needs of our business."

About BioScrip, Inc.

BioScrip provides comprehensive pharmaceutical care solutions. We partner with healthcare payors, pharmaceutical manufacturers, government agencies, physicians, and patients to deliver cost effective programs that enhance the quality of patient life. We focus our products and services in two core areas: Specialty medication distribution and clinical management services, both nationally and community-based, and Pharmacy Benefit Management services. Our specialty medication distribution capabilities include condition-specific clinical management programs tailored to improve the care of individuals with complex health conditions such as HIV/AIDS, Cancer, Infusion IVIG, Hepatitis C, Rheumatoid Arthritis, Multiple Sclerosis, and Transplantation. Our complete pharmacy benefit management programs include customized benefit plan design, pharmacy network management and sophisticated reporting capabilities that deliver improved clinical and economic outcomes. In addition, we have 34 locations including community and infusion pharmacies in major metropolitan markets across the U.S., providing nationwide access and clinical management capabilities in a high-touch community-based environment.

Forward Looking Statements

This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company and our success with respect to the integration and consolidation. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.